PrecisionPhage to Join Leading AMR Conference
We are excited to announce our participation in the AMR Conference 2–4 March 2026 in Basel, Switzerland, one of Europe’s premier gatherings focused on antimicrobial resistance (AMR).
We invite you to visit our Booth #23 if you are attending! At our stand, you can meet us and gain in-depth insights into the Phagenomics BatchQC platform launching in 2026
Phage Technology: A Sustainable Solution to Antibiotic Resistance
Antimicrobial resistance (AMR) is a global crisis.
Antibiotic resistance is growing worldwide, making severe bacterial infections increasingly difficult to treat with existing drugs. This has renewed interest in alternative antimicrobial approaches.
Bacteriophages, viruses that naturally infect and kill specific bacteria, are one of the most promising alternatives. Unlike broad-spectrum antibiotics, phages target individual bacterial species without disrupting the surrounding microbiome. PrecisionPhage develops software and services that support the safe, reliable use of phages in clinical and production settings.
Phages are a promising technology that enables the development of alternative treatments for life-threatening, difficult-to-treat antibiotic-resistant infections. If bacteria become resistant to one phage, another phage can be identified that can destroy it. While only a limited number of antibiotics are available, phages provide vast biological diversity and adaptability.
Read more about phages
PrecisionPhage Provides Modern Phage Solutions
Our team at PrecisionPhage is dedicated to developing modern and globalphage solutions for combating AMR.
We believe phage and computational solutions utilised in infection treatment and biosafety present one of the most promising paths forward. Our presence at AMR Conference2026 underlines our commitment to making an impact.
Founded in 2022 and rooted in robust academic research, PrecisionPhage is a Finland-based biotech company building integrated pipelines for phage isolation, bioinformatics analysis and licensing of bacteriophages.
With collaborations worldwide spanning from pre-clinical development to appliedindustries, we are committed to making phage technology accessible and imactful.
Introducing Phagenomics BatchQC at our Booth #23
We lookforward to connecting with people across industries and engaging indiscussions!
If you are attending AMR Conference 2026, visit us at Booth #23 to meet ourexperts and explore the Phagenomics BatchQC platform, launching in 2026.
Phagenomics BatchQC is a phage genome quality control platform designed for GMP production. It offers a comprehensive, future-readysolution for monitoring phage genome integrity and detecting contamination inGMP production, aligned with evolving regulatory standards, enablingbatch-to-batch consistency.
The lead developer of the software and Chief Technology Officer, Ville Hoikkala, will be available for in-depth discussions about the platform and our broader bioinformatics solutions.
Chief Development Officer, Olli Pitkänen, will also be present to discuss our phage library and licensing portfolio, laboratory and discovery capabilities, and potential collaboration opportunities.
Connect with us
We look forward to meeting you! While our full event schedule will be updated in the spring, you can already explore confirmed conferences here. Reach out to us also in advance: connect with us on LinkedIn
